Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 93 entries
Sorted by: Best Match Show Resources per page
Adrenocortical carcinoma (ACC): diagnosis, prognosis, and treatment.

Frontiers in cell and developmental biology

Libé R.
PMID: 26191527
Front Cell Dev Biol. 2015 Jul 03;3:45. doi: 10.3389/fcell.2015.00045. eCollection 2015.

Adrenocortical carticnoma (ACC) is a rare malignancy with an incidence of 0.7-2.0 cases/million habitants/year. The diagnosis of malignancy relies on careful investigations of clinical, biological, and imaging features before surgery and pathological examination after tumor removal. Most patients present...

Cite
Libé R. Adrenocortical carcinoma (ACC): diagnosis, prognosis, and treatment. Front Cell Dev Biol. 2015;3:45doi: 10.3389/fcell.2015.00045.
Libé, R. (2015). Adrenocortical carcinoma (ACC): diagnosis, prognosis, and treatment. Frontiers in cell and developmental biology, 345. https://doi.org/10.3389/fcell.2015.00045
Libé, Rossella. "Adrenocortical carcinoma (ACC): diagnosis, prognosis, and treatment." Frontiers in cell and developmental biology vol. 3 (2015): 45. doi: https://doi.org/10.3389/fcell.2015.00045
Libé R. Adrenocortical carcinoma (ACC): diagnosis, prognosis, and treatment. Front Cell Dev Biol. 2015 Jul 03;3:45. doi: 10.3389/fcell.2015.00045. eCollection 2015. PMID: 26191527; PMCID: PMC4490795.
Copy Download .nbib Format: NLM
WSES guidelines for emergency repair of complicated abdominal wall hernias.

World journal of emergency surgery : WJES

Sartelli M, Coccolini F, van Ramshorst GH, Campanelli G, Mandalà V, Ansaloni L, Moore EE, Peitzman A, Velmahos G, Moore FA, Leppaniemi A, Burlew CC, Biffl W, Koike K, Kluger Y, Fraga GP, Ordonez CA, Di Saverio S, Agresta F, Sakakushev B, Gerych I, Wani I, Kelly MD, Gomes CA, Faro MP, Taviloglu K, Demetrashvili Z, Lee JG, Vettoretto N, Guercioni G, Tranà C, Cui Y, Kok KY, Ghnnam WM, Abbas Ael-S, Sato N, Marwah S, Rangarajan M, Ben-Ishay O, Adesunkanmi AR, Segovia Lohse HA, Kenig J, Mandalà S, Patrizi A, Scibé R, Catena F.
PMID: 24289453
World J Emerg Surg. 2013 Dec 01;8(1):50. doi: 10.1186/1749-7922-8-50.

Emergency repair of complicated abdominal hernias is associated with poor prognosis and a high rate of post-operative complications.A World Society of Emergency Surgery (WSES) Consensus Conference was held in Bergamo in July 2013, during the 2nd Congress of the...

Cite
Sartelli M, Coccolini F, van Ramshorst GH, et al. WSES guidelines for emergency repair of complicated abdominal wall hernias. World J Emerg Surg. 2013;8(1):50doi: 10.1186/1749-7922-8-50.
Sartelli, M., Coccolini, F., van Ramshorst, G. H., Campanelli, G., Mandalà, V., Ansaloni, L., Moore, E. E., Peitzman, A., Velmahos, G., Moore, F. A., Leppaniemi, A., Burlew, C. C., Biffl, W., Koike, K., Kluger, Y., Fraga, G. P., Ordonez, C. A., Di Saverio, S., Agresta, F., Sakakushev, B., Gerych, I., Wani, I., Kelly, M. D., Gomes, C. A., Faro, M. P., Taviloglu, K., Demetrashvili, Z., Lee, J. G., Vettoretto, N., Guercioni, G., Tranà, C., Cui, Y., Kok, K. Y., Ghnnam, W. M., Abbas, A. e. l. -. S., Sato, N., Marwah, S., Rangarajan, M., Ben-Ishay, O., Adesunkanmi, A. R., Segovia Lohse, H. A., Kenig, J., Mandalà, S., Patrizi, A., Scibé, R., & Catena, F. (2013). WSES guidelines for emergency repair of complicated abdominal wall hernias. World journal of emergency surgery : WJES, 8(1), 50. https://doi.org/10.1186/1749-7922-8-50
Sartelli, Massimo, et al. "WSES guidelines for emergency repair of complicated abdominal wall hernias." World journal of emergency surgery : WJES vol. 8,1 (2013): 50. doi: https://doi.org/10.1186/1749-7922-8-50
Sartelli M, Coccolini F, van Ramshorst GH, Campanelli G, Mandalà V, Ansaloni L, Moore EE, Peitzman A, Velmahos G, Moore FA, Leppaniemi A, Burlew CC, Biffl W, Koike K, Kluger Y, Fraga GP, Ordonez CA, Di Saverio S, Agresta F, Sakakushev B, Gerych I, Wani I, Kelly MD, Gomes CA, Faro MP, Taviloglu K, Demetrashvili Z, Lee JG, Vettoretto N, Guercioni G, Tranà C, Cui Y, Kok KY, Ghnnam WM, Abbas Ael-S, Sato N, Marwah S, Rangarajan M, Ben-Ishay O, Adesunkanmi AR, Segovia Lohse HA, Kenig J, Mandalà S, Patrizi A, Scibé R, Catena F. WSES guidelines for emergency repair of complicated abdominal wall hernias. World J Emerg Surg. 2013 Dec 01;8(1):50. doi: 10.1186/1749-7922-8-50. PMID: 24289453; PMCID: PMC4176144.
Copy Download .nbib Format: NLM
Histological alterations induced by electrode implantation and electrical stimulation in the human brain: a review.

Neuromodulation : journal of the International Neuromodulation Society

van Kuyck K, Welkenhuysen M, Arckens L, Sciot R, Nuttin B.
PMID: 22150838
Neuromodulation. 2007 Jul;10(3):244-61. doi: 10.1111/j.1525-1403.2007.00114.x.

Objectives.  Electrical brain stimulation is used as a treatment for patients with intractable chronic pain and movement disorders. However, the implantation of electrodes and electrical stimulation may induce histological changes around the electrode tip. We aimed to review the...

Cite
van Kuyck K, Welkenhuysen M, Arckens L, et al. Histological alterations induced by electrode implantation and electrical stimulation in the human brain: a review. Neuromodulation. 2007;10(3):244-61doi: 10.1111/j.1525-1403.2007.00114.x.
van Kuyck, K., Welkenhuysen, M., Arckens, L., Sciot, R., & Nuttin, B. (2007). Histological alterations induced by electrode implantation and electrical stimulation in the human brain: a review. Neuromodulation : journal of the International Neuromodulation Society, 10(3), 244-61. https://doi.org/10.1111/j.1525-1403.2007.00114.x
van Kuyck, Kris, et al. "Histological alterations induced by electrode implantation and electrical stimulation in the human brain: a review." Neuromodulation : journal of the International Neuromodulation Society vol. 10,3 (2007): 244-61. doi: https://doi.org/10.1111/j.1525-1403.2007.00114.x
van Kuyck K, Welkenhuysen M, Arckens L, Sciot R, Nuttin B. Histological alterations induced by electrode implantation and electrical stimulation in the human brain: a review. Neuromodulation. 2007 Jul;10(3):244-61. doi: 10.1111/j.1525-1403.2007.00114.x. PMID: 22150838.
Copy Download .nbib Format: NLM
Simulation Modeling to Compare High-Throughput, Low-Iteration Optimization Strategies for Metabolic Engineering.

Frontiers in microbiology

Heinsch SC, Das SR, Smanski MJ.
PMID: 29535690
Front Microbiol. 2018 Feb 27;9:313. doi: 10.3389/fmicb.2018.00313. eCollection 2018.

Increasing the final titer of a multi-gene metabolic pathway can be viewed as a multivariate optimization problem. While numerous multivariate optimization algorithms exist, few are specifically designed to accommodate the constraints posed by genetic engineering workflows. We present a...

Cite
Heinsch SC, Das SR, Smanski MJ. Simulation Modeling to Compare High-Throughput, Low-Iteration Optimization Strategies for Metabolic Engineering. Front Microbiol. 2018;9:313doi: 10.3389/fmicb.2018.00313.
Heinsch, S. C., Das, S. R., & Smanski, M. J. (2018). Simulation Modeling to Compare High-Throughput, Low-Iteration Optimization Strategies for Metabolic Engineering. Frontiers in microbiology, 9313. https://doi.org/10.3389/fmicb.2018.00313
Heinsch, Stephen C, et al. "Simulation Modeling to Compare High-Throughput, Low-Iteration Optimization Strategies for Metabolic Engineering." Frontiers in microbiology vol. 9 (2018): 313. doi: https://doi.org/10.3389/fmicb.2018.00313
Heinsch SC, Das SR, Smanski MJ. Simulation Modeling to Compare High-Throughput, Low-Iteration Optimization Strategies for Metabolic Engineering. Front Microbiol. 2018 Feb 27;9:313. doi: 10.3389/fmicb.2018.00313. eCollection 2018. PMID: 29535690; PMCID: PMC5835107.
Copy Download .nbib Format: NLM
Frequent activation of EGFR in advanced chordomas.

Clinical sarcoma research

Dewaele B, Maggiani F, Floris G, Ampe M, Vanspauwen V, Wozniak A, Debiec-Rychter M, Sciot R.
PMID: 22613809
Clin Sarcoma Res. 2011 Jul 25;1(1):4. doi: 10.1186/2045-3329-1-4. Epub 2011 Jul 25.

BACKGROUND: Chordomas are rare neoplasms, arising from notochordal remnants in the midline skeletal axis, for which the current treatment is limited to surgery and radiotherapy. Recent reports suggest that receptor tyrosine kinases (RTK) might be essential for the survival...

Cite
Dewaele B, Maggiani F, Floris G, et al. Frequent activation of EGFR in advanced chordomas. Clin Sarcoma Res. 2011;1(1):4doi: 10.1186/2045-3329-1-4.
Dewaele, B., Maggiani, F., Floris, G., Ampe, M., Vanspauwen, V., Wozniak, A., Debiec-Rychter, M., & Sciot, R. (2011). Frequent activation of EGFR in advanced chordomas. Clinical sarcoma research, 1(1), 4. https://doi.org/10.1186/2045-3329-1-4
Dewaele, Barbara, et al. "Frequent activation of EGFR in advanced chordomas." Clinical sarcoma research vol. 1,1 (2011): 4. doi: https://doi.org/10.1186/2045-3329-1-4
Dewaele B, Maggiani F, Floris G, Ampe M, Vanspauwen V, Wozniak A, Debiec-Rychter M, Sciot R. Frequent activation of EGFR in advanced chordomas. Clin Sarcoma Res. 2011 Jul 25;1(1):4. doi: 10.1186/2045-3329-1-4. Epub 2011 Jul 25. PMID: 22613809; PMCID: PMC3372284.
Copy Download .nbib Format: NLM
MDM2 Amplified Sarcomas: A Literature Review.

Diagnostics (Basel, Switzerland)

Sciot R.
PMID: 33799733
Diagnostics (Basel). 2021 Mar 11;11(3). doi: 10.3390/diagnostics11030496.

Murine Double Minute Clone 2, located at 12q15, is an oncogene that codes for an oncoprotein of which the association with p53 was discovered 30 years ago. The most important function of MDM2 is to control p53 activity; it...

Cite
Sciot R. MDM2 Amplified Sarcomas: A Literature Review. Diagnostics (Basel). 2021;11(3)doi: 10.3390/diagnostics11030496.
Sciot, R. (2021). MDM2 Amplified Sarcomas: A Literature Review. Diagnostics (Basel, Switzerland), 11(3), . https://doi.org/10.3390/diagnostics11030496
Sciot, Raf. "MDM2 Amplified Sarcomas: A Literature Review." Diagnostics (Basel, Switzerland) vol. 11,3 (2021). doi: https://doi.org/10.3390/diagnostics11030496
Sciot R. MDM2 Amplified Sarcomas: A Literature Review. Diagnostics (Basel). 2021 Mar 11;11(3). doi: 10.3390/diagnostics11030496. PMID: 33799733; PMCID: PMC8001728.
Copy Download .nbib Format: NLM
Comprehensive Molecular Analysis of Inflammatory Myofibroblastic Tumors Reveals Diverse Genomic Landscape and Potential Predictive Markers for Response to Crizotinib.

Clinical cancer research : an official journal of the American Association for Cancer Research

Lee CJ, Schöffski P, Modave E, van Wezel T, Boeckx B, Sufliarsky J, Gelderblom H, Blay JY, Debiec-Rychter M, Sciot R, Bovée JVMG, Lambrechts D, Wozniak A.
PMID: 34551905
Clin Cancer Res. 2021 Dec 15;27(24):6737-6748. doi: 10.1158/1078-0432.CCR-21-1165. Epub 2021 Sep 22.

PURPOSE: The European Organization for Research and Treatment of Cancer (EORTC) clinical phase II trial 90101 "CREATE" showed high antitumor activity of crizotinib, an inhibitor of anaplastic lymphoma kinase (ALK)/ROS1, in patients with advanced inflammatory myofibroblastic tumor (IMFT). However,...

Cite
Lee CJ, Schöffski P, Modave E, et al. Comprehensive Molecular Analysis of Inflammatory Myofibroblastic Tumors Reveals Diverse Genomic Landscape and Potential Predictive Markers for Response to Crizotinib. Clin Cancer Res. 2021;27(24):6737-6748doi: 10.1158/1078-0432.CCR-21-1165.
Lee, C. J., Schöffski, P., Modave, E., van Wezel, T., Boeckx, B., Sufliarsky, J., Gelderblom, H., Blay, J. Y., Debiec-Rychter, M., Sciot, R., Bovée, J. V. M. G., Lambrechts, D., & Wozniak, A. (2021). Comprehensive Molecular Analysis of Inflammatory Myofibroblastic Tumors Reveals Diverse Genomic Landscape and Potential Predictive Markers for Response to Crizotinib. Clinical cancer research : an official journal of the American Association for Cancer Research, 27(24), 6737-6748. https://doi.org/10.1158/1078-0432.CCR-21-1165
Lee, Che-Jui, et al. "Comprehensive Molecular Analysis of Inflammatory Myofibroblastic Tumors Reveals Diverse Genomic Landscape and Potential Predictive Markers for Response to Crizotinib." Clinical cancer research : an official journal of the American Association for Cancer Research vol. 27,24 (2021): 6737-6748. doi: https://doi.org/10.1158/1078-0432.CCR-21-1165
Lee CJ, Schöffski P, Modave E, van Wezel T, Boeckx B, Sufliarsky J, Gelderblom H, Blay JY, Debiec-Rychter M, Sciot R, Bovée JVMG, Lambrechts D, Wozniak A. Comprehensive Molecular Analysis of Inflammatory Myofibroblastic Tumors Reveals Diverse Genomic Landscape and Potential Predictive Markers for Response to Crizotinib. Clin Cancer Res. 2021 Dec 15;27(24):6737-6748. doi: 10.1158/1078-0432.CCR-21-1165. Epub 2021 Sep 22. PMID: 34551905.
Copy Download .nbib Format: NLM
Efficacy and safety of netupitant/palonosetron combination (NEPA) in preventing nausea and vomiting in non-Hodgkin's lymphoma patients undergoing to chemomobilization before autologous stem cell transplantation.

Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer

Di Renzo N, Musso M, Scimè R, Cupri A, Perrone T, De Risi C, Pastore D, Guarini A, Mengarelli A, Benedetti F, Mazza P, Capria S, Chiusolo P, Cupelli L, Federico V, Bozzoli V, Messa AR, Matera R, Seripa D, Codega P, Bonizzoni E, Specchia G.
PMID: 34533630
Support Care Cancer. 2022 Feb;30(2):1521-1527. doi: 10.1007/s00520-021-06495-0. Epub 2021 Sep 17.

PURPOSE: Prevention of chemotherapy-induced nausea and vomiting (CINV) is particularly challenging for patients receiving highly emetogenic preparative regimens before autologous stem cell transplantation (ASCT) due to the daily and continuous emetogenic stimulus of the multiple day chemotherapy. While studies...

Cite
Di Renzo N, Musso M, Scimè R, et al. Efficacy and safety of netupitant/palonosetron combination (NEPA) in preventing nausea and vomiting in non-Hodgkin's lymphoma patients undergoing to chemomobilization before autologous stem cell transplantation. Support Care Cancer. 2021;30(2):1521-1527doi: 10.1007/s00520-021-06495-0.
Di Renzo, N., Musso, M., Scimè, R., Cupri, A., Perrone, T., De Risi, C., Pastore, D., Guarini, A., Mengarelli, A., Benedetti, F., Mazza, P., Capria, S., Chiusolo, P., Cupelli, L., Federico, V., Bozzoli, V., Messa, A. R., Matera, R., Seripa, D., Codega, P., Bonizzoni, E., & Specchia, G. (2022). Efficacy and safety of netupitant/palonosetron combination (NEPA) in preventing nausea and vomiting in non-Hodgkin's lymphoma patients undergoing to chemomobilization before autologous stem cell transplantation. Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer, 30(2), 1521-1527. https://doi.org/10.1007/s00520-021-06495-0
Di Renzo, Nicola, et al. "Efficacy and safety of netupitant/palonosetron combination (NEPA) in preventing nausea and vomiting in non-Hodgkin's lymphoma patients undergoing to chemomobilization before autologous stem cell transplantation." Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer vol. 30,2 (2022): 1521-1527. doi: https://doi.org/10.1007/s00520-021-06495-0
Di Renzo N, Musso M, Scimè R, Cupri A, Perrone T, De Risi C, Pastore D, Guarini A, Mengarelli A, Benedetti F, Mazza P, Capria S, Chiusolo P, Cupelli L, Federico V, Bozzoli V, Messa AR, Matera R, Seripa D, Codega P, Bonizzoni E, Specchia G. Efficacy and safety of netupitant/palonosetron combination (NEPA) in preventing nausea and vomiting in non-Hodgkin's lymphoma patients undergoing to chemomobilization before autologous stem cell transplantation. Support Care Cancer. 2022 Feb;30(2):1521-1527. doi: 10.1007/s00520-021-06495-0. Epub 2021 Sep 17. PMID: 34533630.
Copy Download .nbib Format: NLM
Intraosseous schwannoma of the glenoid: case report and literature review.

SICOT-J

Reyniers P, Wafa H, Sinnaeve F, Debeer P, Sciot R.
PMID: 33416488
SICOT J. 2021;7:2. doi: 10.1051/sicotj/2020048. Epub 2021 Jan 08.

Intraosseous schwannomas represent an extremely rare subgroup of schwannomas, accounting for

Cite
Reyniers P, Wafa H, Sinnaeve F, et al. Intraosseous schwannoma of the glenoid: case report and literature review. SICOT J. 2021;7:2doi: 10.1051/sicotj/2020048.
Reyniers, P., Wafa, H., Sinnaeve, F., Debeer, P., & Sciot, R. (2021). Intraosseous schwannoma of the glenoid: case report and literature review. SICOT-J, 72. https://doi.org/10.1051/sicotj/2020048
Reyniers, Pieter, et al. "Intraosseous schwannoma of the glenoid: case report and literature review." SICOT-J vol. 7 (2021): 2. doi: https://doi.org/10.1051/sicotj/2020048
Reyniers P, Wafa H, Sinnaeve F, Debeer P, Sciot R. Intraosseous schwannoma of the glenoid: case report and literature review. SICOT J. 2021;7:2. doi: 10.1051/sicotj/2020048. Epub 2021 Jan 08. PMID: 33416488; PMCID: PMC7792494.
Copy Download .nbib Format: NLM
S-GRAS score for prognostic classification of adrenocortical carcinoma: an international, multicenter ENSAT study.

European journal of endocrinology

Elhassan YS, Altieri B, Berhane S, Cosentini D, Calabrese A, Haissaguerre M, Kastelan D, Fragoso MCBV, Bertherat J, Al Ghuzlan A, Haak H, Boudina M, Canu L, Loli P, Sherlock M, Kimpel O, Laganà M, Sitch AJ, Kroiss M, Arlt W, Terzolo M, Berruti A, Deeks JJ, Libé R, Fassnacht M, Ronchi CL.
PMID: 34709200
Eur J Endocrinol. 2021 Nov 30;186(1):25-36. doi: 10.1530/EJE-21-0510.

OBJECTIVE: Adrenocortical carcinoma (ACC) has an aggressive but variable clinical course. Prognostic stratification based on the European Network for the Study of Adrenal Tumours stage and Ki67 index is limited. We aimed to demonstrate the prognostic role of a...

Cite
Elhassan YS, Altieri B, Berhane S, et al. S-GRAS score for prognostic classification of adrenocortical carcinoma: an international, multicenter ENSAT study. Eur J Endocrinol. 2021;186(1):25-36doi: 10.1530/EJE-21-0510.
Elhassan, Y. S., Altieri, B., Berhane, S., Cosentini, D., Calabrese, A., Haissaguerre, M., Kastelan, D., Fragoso, M. C. B. V., Bertherat, J., Al Ghuzlan, A., Haak, H., Boudina, M., Canu, L., Loli, P., Sherlock, M., Kimpel, O., Laganà, M., Sitch, A. J., Kroiss, M., Arlt, W., Terzolo, M., Berruti, A., Deeks, J. J., Libé, R., Fassnacht, M., & Ronchi, C. L. (2021). S-GRAS score for prognostic classification of adrenocortical carcinoma: an international, multicenter ENSAT study. European journal of endocrinology, 186(1), 25-36. https://doi.org/10.1530/EJE-21-0510
Elhassan, Y S, et al. "S-GRAS score for prognostic classification of adrenocortical carcinoma: an international, multicenter ENSAT study." European journal of endocrinology vol. 186,1 (2021): 25-36. doi: https://doi.org/10.1530/EJE-21-0510
Elhassan YS, Altieri B, Berhane S, Cosentini D, Calabrese A, Haissaguerre M, Kastelan D, Fragoso MCBV, Bertherat J, Al Ghuzlan A, Haak H, Boudina M, Canu L, Loli P, Sherlock M, Kimpel O, Laganà M, Sitch AJ, Kroiss M, Arlt W, Terzolo M, Berruti A, Deeks JJ, Libé R, Fassnacht M, Ronchi CL. S-GRAS score for prognostic classification of adrenocortical carcinoma: an international, multicenter ENSAT study. Eur J Endocrinol. 2021 Nov 30;186(1):25-36. doi: 10.1530/EJE-21-0510. PMID: 34709200.
Copy Download .nbib Format: NLM
Establishment of an Academic Tissue Microarray Platform as a Tool for Soft Tissue Sarcoma Research.

Sarcoma

Lee CJ, Wozniak A, Van Cann T, Timmermans I, Wellens J, Vanleeuw U, Briaire-de Bruijn IH, Britschgi C, Bovée JVMG, Zlobec I, Sciot R, Schöffski P.
PMID: 34413700
Sarcoma. 2021 Mar 15;2021:6675260. doi: 10.1155/2021/6675260. eCollection 2021.

Soft tissue sarcoma (STS) is a heterogeneous family of rare mesenchymal tumors, characterized by histopathological and molecular diversity. Tissue microarray (TMA) is a tool that allows performing research in orphan diseases in a more efficient and cost-effective way. TMAs...

Cite
Lee CJ, Wozniak A, Van Cann T, et al. Establishment of an Academic Tissue Microarray Platform as a Tool for Soft Tissue Sarcoma Research. Sarcoma. 2021;2021:6675260doi: 10.1155/2021/6675260.
Lee, C. J., Wozniak, A., Van Cann, T., Timmermans, I., Wellens, J., Vanleeuw, U., Briaire-de Bruijn, I. H., Britschgi, C., Bovée, J. V. M. G., Zlobec, I., Sciot, R., & Schöffski, P. (2021). Establishment of an Academic Tissue Microarray Platform as a Tool for Soft Tissue Sarcoma Research. Sarcoma, 20216675260. https://doi.org/10.1155/2021/6675260
Lee, Che-Jui, et al. "Establishment of an Academic Tissue Microarray Platform as a Tool for Soft Tissue Sarcoma Research." Sarcoma vol. 2021 (2021): 6675260. doi: https://doi.org/10.1155/2021/6675260
Lee CJ, Wozniak A, Van Cann T, Timmermans I, Wellens J, Vanleeuw U, Briaire-de Bruijn IH, Britschgi C, Bovée JVMG, Zlobec I, Sciot R, Schöffski P. Establishment of an Academic Tissue Microarray Platform as a Tool for Soft Tissue Sarcoma Research. Sarcoma. 2021 Mar 15;2021:6675260. doi: 10.1155/2021/6675260. eCollection 2021. PMID: 34413700; PMCID: PMC8369337.
Copy Download .nbib Format: NLM
Genomic classification of benign adrenocortical lesions.

Endocrine-related cancer

Faillot S, Foulonneau T, Néou M, Espiard S, Garinet S, Vaczlavik A, Jouinot A, Rondof W, Septier A, Drougat L, Hécale-Perlemoine K, Ragazzon B, Rizk-Rabin M, Sibony M, Bonnet-Serrano F, Guibourdenche J, Libé R, Groussin L, Dousset B, de Reyniès A, Bertherat J, Assié G.
PMID: 33151900
Endocr Relat Cancer. 2021 Jan;28(1):79-95. doi: 10.1530/ERC-20-0128.

Benign adrenal tumors cover a spectrum of lesions with distinct morphology and steroid secretion. Current classification is empirical. Beyond a few driver mutations, pathophysiology is not well understood. Here, a pangenomic characterization of benign adrenocortical tumors is proposed, aiming...

Cite
Faillot S, Foulonneau T, Néou M, et al. Genomic classification of benign adrenocortical lesions. Endocr Relat Cancer. 2021;28(1):79-95doi: 10.1530/ERC-20-0128.
Faillot, S., Foulonneau, T., Néou, M., Espiard, S., Garinet, S., Vaczlavik, A., Jouinot, A., Rondof, W., Septier, A., Drougat, L., Hécale-Perlemoine, K., Ragazzon, B., Rizk-Rabin, M., Sibony, M., Bonnet-Serrano, F., Guibourdenche, J., Libé, R., Groussin, L., Dousset, B., de Reyniès, A., Bertherat, J., & Assié, G. (2021). Genomic classification of benign adrenocortical lesions. Endocrine-related cancer, 28(1), 79-95. https://doi.org/10.1530/ERC-20-0128
Faillot, Simon, et al. "Genomic classification of benign adrenocortical lesions." Endocrine-related cancer vol. 28,1 (2021): 79-95. doi: https://doi.org/10.1530/ERC-20-0128
Faillot S, Foulonneau T, Néou M, Espiard S, Garinet S, Vaczlavik A, Jouinot A, Rondof W, Septier A, Drougat L, Hécale-Perlemoine K, Ragazzon B, Rizk-Rabin M, Sibony M, Bonnet-Serrano F, Guibourdenche J, Libé R, Groussin L, Dousset B, de Reyniès A, Bertherat J, Assié G. Genomic classification of benign adrenocortical lesions. Endocr Relat Cancer. 2021 Jan;28(1):79-95. doi: 10.1530/ERC-20-0128. PMID: 33151900.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 93 entries